Teczine – 5mg TABLETS 10’s

Description

Teczine – TABLETS 

1. Active Ingredient

• Levocetirizine Dihydrochloride: The active ingredient in Teczine is Levocetirizine, a second-generation antihistamine. It is the active enantiomer of cetirizine, which means it works by blocking histamine receptors in the body, helping to reduce allergic reactions such as itching, swelling, and irritation caused by histamines.

2. Dosage and Administration

• Dosage for Adults:
  Typically, 5 mg (1 tablet) once daily in the evening.
• Dosage for Children:
  • Children 6-12 years: 2.5 mg (half a tablet) once daily.
  • Children 2-6 years: The dose may vary depending on weight and age, and it should be prescribed by a healthcare provider.
• Mode of Administration:
  • Oral tablets: The tablets should be swallowed whole with water. They can be taken with or without food.

3. Indications

• Allergic Rhinitis (Hay Fever):
  Teczine is used to treat symptoms like sneezing, runny nose, and itchy/watery eyes due to pollen or other allergens.
• Urticaria (Hives):
  It helps reduce itching and swelling associated with hives or urticaria.
• Conjunctivitis:
  It alleviates symptoms of eye allergies like redness, itching, and watering.

4. Side Effects

Like all medications, Teczine may cause side effects, though not everyone experiences them. Common and serious side effects include:

• Common Side Effects:
  • Headache
  • Dry mouth
  • Drowsiness (though less common compared to first-generation antihistamines)
  • Fatigue
• Serious Side Effects (rare):
  • Swelling of the face, tongue, or throat (severe allergic reactions)
  • Difficulty breathing
  • Unusual thoughts or behaviors
  • Seizures
  • Jaundice (yellowing of the skin/eyes)

If any of these occur, immediate medical attention is required.

5. Precautions

Before taking Teczine, ensure the following:

• Kidney Issues:
  People with severe kidney problems should adjust their dosage, as the medication is primarily excreted through the kidneys. Kidney function should be monitored.
• Pregnancy and Breastfeeding:
  • Pregnancy: There is limited data on the safety of Levocetirizine during pregnancy. It should only be used when the potential benefits outweigh the risks.
  • Breastfeeding: Levocetirizine passes into breast milk, and its use is not recommended for breastfeeding mothers without a doctor’s advice.
• Alcohol:
  Alcohol may enhance drowsiness, so it’s recommended to avoid alcohol while taking this medication.

6. Drug Interactions

Levocetirizine may interact with other medications, particularly other sedating drugs or those affecting the central nervous system (CNS). Some drugs that may interact include:

• Central Nervous System Depressants (e.g., sedatives, tranquilizers, alcohol): This may increase the sedative effects.
• Theophylline: A medication used for asthma and other respiratory conditions may increase the levels of Levocetirizine in the blood.

Always consult a healthcare provider or pharmacist before taking Levocetirizine with other medications.

7. Overdose

If an overdose occurs, the person should seek immediate medical help. Symptoms of overdose may include:

• Drowsiness or lethargy
• Tachycardia (rapid heartbeat)
• Agitation
• Tremors

8. Special Populations

• Elderly:
  No specific dosage adjustments are required unless the individual has kidney problems.
• Children:
  Dosage is adjusted based on age and weight. Always follow the pediatrician’s instructions.

9. Packaging

A strip of 10 tablets is typically available. Each tablet contains 5 mg of Levocetirizine dihydrochloride. The tablets are typically white or off-white and come in blister packaging.

10. Storage

• Store Teczine tablets at room temperature, 15°C to 25°C (59°F to 77°F).
• Keep the medication away from light, moisture, and heat.
• Keep out of reach of children.

11. Manufacturer

Teczine is produced by pharmaceutical companies that specialize in allergy medications, such as Cipla, Medi-Sun, or others depending on the region.

12. Brand Names

Levocetirizine is sold under various brand names, including Teczine, Xyzal, and Levocet in different regions, with formulations available as tablets, syrups, and oral solutions.